|
API |
|
RPG Life Sciences offers a range of high value synthetic APIs in the general therapeutic category. With presence in Europe, Latin America and Asia, RPGLS is making forays into the US markets.
With a strong focus on R&D, the API business is building a robust product pipeline to enable new product launches consistently.
Our growing product portfolio having US & EU DMFs in eCTD Formats cover following therapeutic categories:
-
Immunosuppressants
-
Anti-psychotic / Anti-depressant, Anti-thrombotic,
Anti-anginal
-
Anti-helmentic, Anti-convulsant,
Anti-spasmodic
-
Anti-cancer
Our modern facilities are approved by TGA and several other regulatory agencies as well as
various international pharmaceutical companies. View Manufacturing Facility
Synthetic API --
View Product Details
Partner with RPGLS
RPG Life Sciences is a reliable partner with high sensitivity to cater to explicit customer requirements
Read more...
|
|
API